By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Contraceptives > Cryselle 28 > Ethinyl Estradiol / Norgestrel Dosage
Contraceptives
https://themeditary.com/dosage-information/ethinyl-estradiol-norgestrel-dosage-2164.html

Ethinyl Estradiol / Norgestrel Dosage

Drug Detail:Cryselle 28 (Ethinyl estradiol and norgestrel [ eth-in-il-ess-tra-dye-ol-and-nor-jess-trel ])

Drug Class: Contraceptives

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Contraception

1 tablet orally once a day

Comments:

  • To be taken at the same time each day.
  • Correct and consistent use can result in low failure rates.
  • Withdrawal bleeding usually occurs within 3 days after discontinuing active tablets.

Use: For the prevention of pregnancy in women who elect to use this product as a method of contraception

Usual Pediatric Dose for Contraception

1 tablet orally once a day

Comments:

  • To be taken at the same time each day.
  • Correct and consistent use can result in low failure rates.
  • Withdrawal bleeding usually occurs within 3 days after discontinuing active tablets.

Use: For the prevention of pregnancy in women who elect to use this product as a method of contraception

Renal Dose Adjustments

Use with caution; other methods of contraception should be considered in patients with renal disease.

Liver Dose Adjustments

Active liver disease: Contraindicated

Precautions

US BOXED WARNING: SERIOUS CARDIOVASCULAR ADVERSE EFFECTS:

  • Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.

Safety and efficacy have been established in female patients of reproductive age; use prior to menarche is not indicated.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For maximum effectiveness, this drug must be taken exactly as directed and at intervals not exceeding 24 hours.
  • Tablets should be taken at the same time each day.
  • The active tablets are to be taken consistently once a day for 21 days, followed by the inert tablets once a day for 7 days.
  • Backup birth control should be used until the active tablets have been taken consistently for 7 days; some manufacturers recommend using a backup method for the first 7 days in either administration course (i.e. day 1 start or Sunday start).
  • Spotting or breakthrough bleeding may occur, however the same regimen should be continued as this type of bleeding is usually transient; however, if the bleeding is persistent or prolonged, a physician should be consulted.
  • Pregnancy should be considered at the first missed period and ruled out before continuing use in any patient that has missed 2 consecutive periods.
  • Some manufacturers recommend a Sunday start upon starting the first pack of oral contraceptives; the manufacturer product information should be consulted.
  • Whichever method of administration is chosen (i.e. day 1 start or Sunday start), the patient should continue to start each subsequent pack on the same day of the week.

Sunday Start:
  • Take the first active pill on the Sunday after the period starts, even if the patient is still bleeding; if the period begins on a Sunday, start the pack the same day.
  • A backup form of birth control (e.g., condoms) should be used from the Sunday the pills are started to the next Sunday (7 days)

Day 1 Start:
  • Take the first active pill during the first 24 hours of starting the period.
  • A backup method of birth control will not be necessary with the Day 1 start.

Missed Pills:
  • If 1 active pill is missed, take it as soon as it is remembered and the next pill at the regular time (2 pills in 1 day); a backup birth control method is not necessary
  • If 2 active pills are missed in a row on week 1 or week 2 of the pack, take 2 pills on the day they are remembered and 2 pills the next day, then 1 pill each day until the pack is finished; a form of back-up birth control is necessary for the next 7 days
  • If 2 active pills are missed in a row on Week 3, or 3 or more pills are missed in a row, the rest of the pill pack should be thrown out and a new pack started the same day for Day 1 starters; for Sunday starters, keep taking 1 pill every day until Sunday, then on Sunday, throw out the rest of the pack and start a new pack of pills the same day; back-up birth control is necessary for the next 7 days

General:
  • The use of oral contraceptives is associated with increased risks of serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, gallbladder disease, and hypertension; although risk of serious morbidity or mortality is low in healthy women without underlying risk factors.
  • The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity, and diabetes.
  • Noncontraceptive health benefits related to oral contraceptives include: increased menstrual cycle regularity, decreased blood loss, decreased incidence of iron-deficiency anemia, decreased incidence of dysmenorrhea, decreased incidence of functional ovarian cysts, decreased incidence of ectopic pregnancies, decreased incidence of fibroadenomas and fibrocystic disease of the breast, decreased incidence of acute pelvic inflammatory disease, decreased incidence of endometrial cancer, and decreased incidence of ovarian cancer.

Patient advice:
  • This drug does not protect against HIV infection, AIDS, and other sexually transmitted diseases.
  • Smoking while using this drug is not recommended as it increases the risk of thromboembolism.
  • Consult your physician if you are breastfeeding; some authorities recommend to not initiate this medication until 4 to 6 weeks after a full-term delivery.
  • If pregnancy is terminated in the first 12 weeks, oral contraceptives should be initiated immediately or within 7 days.
  • If pregnancy is terminated after 12 weeks, oral contraceptives should be initiated after 2 weeks.
  • The patient information leaflet should be consulted for further information.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by